Keller Gerry sold $343K of MTD

Keller Gerry (Head of Process Analytics) sold 240 shares of METTLER TOLEDO INTERNATIONAL INC/ (MTD) at $1427.14 ($0.34M total) on 2026-08-03.

Original reporting
SEC EDGAR · Keller Gerry
Published Aug 5, 2026, 1:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 1:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MTD
Neutral
medium confidence
Mentioned
$MTD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MTDNeutralLow
01

Why it matters

This is a disclosure of an open-market sale of 240 shares at $1,427.14 per share, totaling $342,513.60, with holdings after sale of 259 shares.

02

Market read

Traders may note insider-selling optics, but there is no new operational or financial information about Mettler Toledo in the text.

03

What to watch

The filing does not state reasons for sale, tax events, or whether other insiders are buying/selling around the same period; without that context, signal quality is low.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for Mettler Toledo International, filed by an officer (Head of Process Analytics).

Company-level read

Ticker impact

$MTDNeutralMedium confidence
Context

SEC Form 4 shows Mettler Toledo insider Keller Gerry sold 240 shares on 2026-08-03 for about $342.5K.

Expected impact

Low likelihood of a sustained price move; any impact is likely limited to short-term sentiment/flow optics.

Evidence & confidence

The filing is a Form 4 insider transaction, not a company disclosure of earnings, guidance, or operational change. The disclosed size is modest relative to typical market cap impact, and the article provides no additional company-specific catalyst.

Market effects

Minimal. Insider sales do not typically reset sector expectations without accompanying company news.

None indicated.

None indicated.

Counterpoint

The sale could be planned for personal liquidity or diversification, and the absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • Mettler Toledo International Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Keller Gerry

    Officer (Head of Process Analytics) who sold 240 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MTDHighAI 8/10

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway?

Mettler-Toledo's stock rose 25% despite biotech funding freeze. Management's 2026 EPS guidance of $47.70-$47.90 exceeds consensus, with 2027 guidance also above expectations. Analysts' average price target is $1,590, but some, like Jefferies, raised targets to $1,930. The company expects $900M in free cash flow, supporting an $875M share buyback. Growth drivers include pharmacopeia revisions and GLP-1 manufacturing. Investors should evaluate service revenue and hardware cycles.

$MTDMed

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway? By Investing.com RSS CTA

Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.

$MTDMedAI 8/10

What Mettler-Toledo International (MTD) Said on Its Q3 Earnings Call

Mettler-Toledo (MTD) reported Q3 gross margin expansion to 59.8% and adjusted operating profit growth of 8%. The company raised its 2026 sales growth forecast to 5% and issued 2027 guidance, expecting 5% sales growth and adjusted EPS of $52.50-$53.50. Management highlighted opportunities in automation, digitalization, and U.S. onshoring, with potential upside from AI-driven instrument upgrades.

$MTDMed

Jefferies raises Mettler-Toledo stock price target on solid growth

Jefferies raised its price target for Mettler-Toledo (MTD) to $1,930, citing strong Q3 results with 6% local currency growth and improved 2026 outlook. The stock trades near its 52-week high, up 26.5% in six months. MTD reported Q3 adjusted earnings of $12.57 per share and revenue of $1.09 billion, both exceeding estimates. The company provided initial 2027 guidance with 5% growth and EPS of $52.50-$53.50, above consensus.